Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis.

Pollari S, Käkönen SM, Edgren H, Wolf M, Kohonen P, Sara H, Guise T, Nees M, Kallioniemi O.

Breast Cancer Res Treat. 2011 Jan;125(2):421-30. doi: 10.1007/s10549-010-0848-5. Epub 2010 Mar 30. Erratum in: Breast Cancer Res Treat. 2012 Feb;131(3):1085-6.

PMID:
20352489
2.

Functional genomics reveal that the serine synthesis pathway is essential in breast cancer.

Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, Sethumadhavan S, Woo HK, Jang HG, Jha AK, Chen WW, Barrett FG, Stransky N, Tsun ZY, Cowley GS, Barretina J, Kalaany NY, Hsu PP, Ottina K, Chan AM, Yuan B, Garraway LA, Root DE, Mino-Kenudson M, Brachtel EF, Driggers EM, Sabatini DM.

Nature. 2011 Aug 18;476(7360):346-50. doi: 10.1038/nature10350.

3.

Parathyroid hormone-related protein and bone metastases.

Guise TA.

Cancer. 1997 Oct 15;80(8 Suppl):1572-80. Review.

PMID:
9362424
4.

Neu-Laxova syndrome is a heterogeneous metabolic disorder caused by defects in enzymes of the L-serine biosynthesis pathway.

Acuna-Hidalgo R, Schanze D, Kariminejad A, Nordgren A, Kariminejad MH, Conner P, Grigelioniene G, Nilsson D, Nordenskjöld M, Wedell A, Freyer C, Wredenberg A, Wieczorek D, Gillessen-Kaesbach G, Kayserili H, Elcioglu N, Ghaderi-Sohi S, Goodarzi P, Setayesh H, van de Vorst M, Steehouwer M, Pfundt R, Krabichler B, Curry C, MacKenzie MG, Boycott KM, Gilissen C, Janecke AR, Hoischen A, Zenker M.

Am J Hum Genet. 2014 Sep 4;95(3):285-93. doi: 10.1016/j.ajhg.2014.07.012. Epub 2014 Aug 21.

5.
7.

Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis.

Pollari S, Käkönen RS, Mohammad KS, Rissanen JP, Halleen JM, Wärri A, Nissinen L, Pihlavisto M, Marjamäki A, Perälä M, Guise TA, Kallioniemi O, Käkönen SM.

Mol Cancer Res. 2012 May;10(5):597-604. doi: 10.1158/1541-7786.MCR-11-0482. Epub 2012 Apr 20.

8.

On the phenotypic spectrum of serine biosynthesis defects.

El-Hattab AW, Shaheen R, Hertecant J, Galadari HI, Albaqawi BS, Nabil A, Alkuraya FS.

J Inherit Metab Dis. 2016 May;39(3):373-381. doi: 10.1007/s10545-016-9921-5. Epub 2016 Mar 10.

PMID:
26960553
9.

Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer.

Min Y, Ren X, Vaught DB, Chen J, Donnelly E, Lynch CC, Lin PC.

Cancer Res. 2010 Apr 1;70(7):2819-28. doi: 10.1158/0008-5472.CAN-09-1915. Epub 2010 Mar 16.

10.

Gallium, a promising candidate to disrupt the vicious cycle driving osteolytic metastases.

Strazic-Geljic I, Guberovic I, Didak B, Schmid-Antomarchi H, Schmid-Alliana A, Boukhechba F, Bouler JM, Scimeca JC, Verron E.

Biochem Pharmacol. 2016 Sep 15;116:11-21. doi: 10.1016/j.bcp.2016.06.020. Epub 2016 Jul 1.

PMID:
27378505
11.

Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.

Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W, Yuan Z.

BMC Cancer. 2009 Apr 1;9:102. doi: 10.1186/1471-2407-9-102.

12.

Identification of microRNAs inhibiting TGF-β-induced IL-11 production in bone metastatic breast cancer cells.

Pollari S, Leivonen SK, Perälä M, Fey V, Käkönen SM, Kallioniemi O.

PLoS One. 2012;7(5):e37361. doi: 10.1371/journal.pone.0037361. Epub 2012 May 21.

13.

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

Breast Cancer Res. 2007;9(6):R76.

14.

MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases.

Pivetta E, Scapolan M, Pecolo M, Wassermann B, Abu-Rumeileh I, Balestreri L, Borsatti E, Tripodo C, Colombatti A, Spessotto P.

Breast Cancer Res. 2011 Oct 27;13(5):R105. doi: 10.1186/bcr3047.

15.

MAPK11 in breast cancer cells enhances osteoclastogenesis and bone resorption.

He Z, He J, Liu Z, Xu J, Yi SF, Liu H, Yang J.

Biochimie. 2014 Nov;106:24-32. doi: 10.1016/j.biochi.2014.07.017. Epub 2014 Jul 24.

16.

Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.

Park HR, Min SK, Cho HD, Kim DH, Shin HS, Park YE.

J Korean Med Sci. 2003 Aug;18(4):541-6.

17.

NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF.

Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T, Gu K, Shah V, Pei L, Zarbo RJ, McCauley L, Shi S, Chen S, Wang CY.

Nat Med. 2007 Jan;13(1):62-9. Epub 2006 Dec 10.

PMID:
17159986
18.

Correlation between extent of osteolytic damage and metastatic burden of human breast cancer metastasis in nude mice: real-time PCR quantitation.

Tester AM, Sharp JA, Dhanesuan N, Waltham M, Thompson EW.

Clin Exp Metastasis. 2002;19(5):377-83.

PMID:
12198765
19.

Enpp1: a potential facilitator of breast cancer bone metastasis.

Lau WM, Doucet M, Stadel R, Huang D, Weber KL, Kominsky SL.

PLoS One. 2013 Jul 5;8(7):e66752. doi: 10.1371/journal.pone.0066752. Print 2013.

20.

p73 regulates serine biosynthesis in cancer.

Amelio I, Markert EK, Rufini A, Antonov AV, Sayan BS, Tucci P, Agostini M, Mineo TC, Levine AJ, Melino G.

Oncogene. 2014 Oct 16;33(42):5039-46. doi: 10.1038/onc.2013.456. Epub 2013 Nov 4.

PMID:
24186203

Supplemental Content

Support Center